- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is an 8-week randomised placebo controlled trial of OROS-MPH, in young adult prisoners meeting diagnostic criteria for ADHD. OROS-MPH is a long acting stimulant medication used to treat ADHD. The primary objective is to establish the efficacy of OROS-MPH in reducing ADHD symptoms (inattention and hyperactivity-impulsivity) in young male offenders aged 16-25, meeting diagnostic criteria for DSM-5 ADHD.
Critère d'inclusion
- Attention-Deficit/Hyperactivity Disorder (ADHD)